Biogen cuts the price tag on its Alzheimer’s drug in half

December 20, 2021

Biogen is slashing the price of its Alzheimer’s treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.

Cancer researchers identify the 'switch' that allows intestinal cells to regenerate after injury
Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer.
Neutrophils' mitochondrial sensing disrupted in lupus patients, study finds
Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect infection and how that fails to happen in people with lupus.
Fusing two immune system proteins leads to a new method of generating antibodies
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to advance research projects.
Meniscus injuries may soon be treated by customizable hydrogel
Meniscus tears are common knee injuries that have long frustrated patients and doctors due to limited repair options. A new 3D-printed hydrogel made from cow meniscus could transform how these injuries heal, according to results of a pre-clinical study published in Bioactive Materials from researchers in the Perelman School of Medicine at the University of Pennsylvania.
Measles cases hit 370 total in Texas and New Mexico. Kansas has an outbreak. Here's what to know
The measles outbreaks in West Texas and New Mexico have surpassed a combined 370 cases, and two unvaccinated people have died from measles-related causes.

Biogen cuts the price tag on its Alzheimer’s drug in half

Recent Posts

JUST IN